
Founded in 1997, Digital Diagnostics Inc. is an AI diagnostics company offering management consulting services.
Founded in 1997, Digital Diagnostics Inc. is an AI diagnostics company dedicated to transforming global healthcare through artificial intelligence. The company's core mission is to pioneer medical care with AI, offering innovative solutions to enhance diagnostic accuracy and efficiency. Their flagship product, LumineticsCore™, is an AI diagnostic system that autonomously diagnoses patients for diabetic retinopathy, including macular edema. Digital Diagnostics primarily focuses on integrating advanced AI technologies into healthcare to improve patient outcomes and streamline clinical workflows.
Notable figures affiliated with Digital Diagnostics include experts in AI and healthcare, though specific names are not provided. The company has secured investments from leading venture capital firms specializing in health tech innovations. Key achievements include the successful deployment of LumineticsCore™ in various clinical settings, demonstrating significant improvements in diagnostic accuracy and early detection of diabetic retinopathy. Overall, Digital Diagnostics has made a substantial impact on the healthcare industry by leveraging AI to enhance diagnostic processes and patient care.
Companies similar to Digital Diagnostics include Aeye Health, Retina-Ai Health, Predictive Health Diagnostics Company and Ocular Diagnostics.
Digital Diagnostics was founded in 2010.
Digital Diagnostics' headquarters is located in Coralville, IA, US.
Digital Diagnostics' most recent funding round was for $75M (USD) in August 2022.
As of Aug 23, 2022, Digital Diagnostics has raised a total of $173.4M (USD).
Digital Diagnostics has 122 employees as of Feb 5, 2024.
Predictive Health Diagnostics Company